
Gaining the trust and confidence of women is more important than ever in encouraging health screenings. To support radiologists and imaging centers with better tools to do their best work for Women’s’ Health, CureMetrix will be featuring the best in Artificial Intelligence (AI) at SBI 2022.
------------------------------------------------------------------------
TUESEDAY, MAY 17 - 12:15 PM EDT
Live Presentation | Product Theater Stage
BEYOND BREAST CANCER – EXTENDING THE VALUE OF MAMMOGRAPHY FOR WOMEN’S HEALTH
Extending the use of the mammogram and creating more value for the radiologist, this discussion will review new and national research on the evolution of the AI-based Mammogram. Discussion will include an overview of how stratifying the risk of Coronary Heart Disease (CHD) by detecting and quantifying Breast Arterial Calcifications (BAC) can benefit imaging centers, healthcare systems, and millions of women.
Presenters:
Kevin Harris, President, CureMetrix.
Alyssa Watanabe, MD, FACR, Chief Medical Officer CureMetrix
------------------------------------------------------------------------
WEDNESDAY, MAY 18 - 1:30 PM EDT
HIGH PERFORMANCE OF AI-BASED MODEL FOR SCORING BAC ON MAMMOGRAMS
Artificial intelligence (AI) has impacted all areas of our industry: reducing reading time, increasing cancer detection, and reducing false positives. And now, AI is also bringing clinicians and specialties together to extend the value of radiology to address the #1 killer of women, heart disease.
In this presentation, Dr. Nerlekar, cardiologist and cardiac imaging specialist, will discuss the results from his assessment of the external validity of a novel Breast Arterial Calcification (BAC) quantification score using CureMetrix cmAngio™
Presenter: Nitesh Nerlekar, MD, MPH, PhD – Cardiologist and Cardiac Imaging Specialist – MonashHeart & MonashHealth
------------------------------------------------------------------------
CureMetrix Women's Health Solutions:
cmTriage® – The first FDA-cleared AI-based triage solution for mammography in the U.S. Enables radiologists to triage, sort and prioritize mammography worklists based on suspicious cases that may need immediate attention.
cmAssist® – A novel AI-based CAD intended to identify, mark and score regions of interest on screening and diagnostic mammograms.
cmDensity™ – An AI-based triage solution for mammography designed to help radiologists classify density accurately, consistently, and quickly with a high level of confidence.
cmAngio™ – A novel AI-based software intended to help doctors find, score and assess a patient’s risk of coronary heart disease (CHD) from a mammogram.
Artificial Intelligence / Machine LearningComputer Aided Diagnosis (CAD)Imaging Services